Influenza B virus genomic RNA

Influenza B virus genomic RNA consists of eight segments of single-stranded negative-sense RNA, each packaged with viral nucleoprotein (NP) and associated with a trimeric RNA-dependent RNA polymerase complex (composed of PB1, PB2, and PA subunits) to form viral ribonucleoproteins (vRNPs). These vRNPs are responsible for transcription and replication of the viral genome inside host cell nuclei. The RNA serves as both genetic material and as a template for synthesis of viral mRNAs and new genomic RNA segments. Influenza B is a major cause of seasonal influenza in humans, but the vRNA itself is not considered a canonical therapeutic target; rather, viral proteins interacting with the RNA (notably the polymerase complex and NP) are directly targeted by antiviral drugs and small molecules. Aberrant forms of viral RNAs (defective interfering RNAs and mini viral RNAs) can also modulate immune responses. Direct targeting of the viral RNA is rare, with most drugs acting on enzymes or structural proteins that bind or replicate the RNA.[1][2][3][4] Key points and justifications: - **is_target: false** — The **genomic RNA** itself is not considered a direct pharmacological target; therapeutic intervention primarily targets the viral polymerase or NP, which interact with the RNA. Most antiviral drugs for influenza B inhibit the viral polymerase or block cap-snatching, not the vRNA directly[1][2][3]. - **is_incorrect: true** — "Influenza B viral RNA" is not a canonical drug target but the viral genome; the usual drug targets are **Influenza B virus RNA-dependent RNA polymerase** or **Nucleoprotein**. The RNA is the substrate, not a receptor, enzyme, or protein target typically cataloged in drug target databases. - **aliases** include common alternative descriptions for the viral genome. - **molecular_classifications:** As the genetic material of a virus, this RNA is classified under "Other" (not enzyme, receptor, etc.). - **disease_roles:** Restricted to infection, as the RNA is core to viral replication. - **interacting_drugs/mechanisms of action:** Drugs do not bind the vRNA directly but prevent its transcription/replication by binding viral polymerase or NP[1][2][3]. - **biological_functions:** Describes its central role as genetic material and template for viral processes[1][3]. - **biomarkers/safety_concerns:** None established for the RNA itself. - **description:** Synthesizes structural context from structural biology and virology sources[1][2][3][4].

Other names

Influenza B viral RNAInfluenza B virus RNAInfluenza B vRNA

Inhibitors of viral RNA-dependent RNA polymerase block synthesis of viral mRNA and replication of vRNA[1] Cap-snatching inhibitors prevent transcription initiation using vRNA as template